# KIZ1140

# 5510(k) Summary- PROLYTE Electrolyte Analyzer $N a + / K + / C l - / L i +$

(1) Submitted by:

Diamond Diagnostics 333 Fiske St. Holliston, MA 01746 (2) Contact Person:

Kathy Cruz, Quality Assurance Manager Phone: 508-429-0450 (x358) Fax: 508-429-0452 E-mail: kcruz@diamonddiagnostics.com (3) Summary Prepared: April 13, 2012 (4) Device Trade Name:

PROLYTE Electrolyte Analyzer Na\*/K†/CI/Li\* (5) Regulatory Information:

<table><tr><td rowspan=1 colspan=1>Description</td><td rowspan=1 colspan=1>CFR Section</td><td rowspan=1 colspan=1>Device Class</td><td rowspan=1 colspan=1>Product Code</td></tr><tr><td rowspan=1 colspan=1>Sodium Test System</td><td rowspan=1 colspan=1>862.1665</td><td rowspan=1 colspan=1>Class II</td><td rowspan=1 colspan=1>JGS</td></tr><tr><td rowspan=1 colspan=1>Potassium Test System</td><td rowspan=1 colspan=1>862.1600</td><td rowspan=1 colspan=1>Class II</td><td rowspan=1 colspan=1>CEM</td></tr><tr><td rowspan=1 colspan=1>Chloride Test System</td><td rowspan=1 colspan=1>862.1170</td><td rowspan=1 colspan=1>Class II</td><td rowspan=1 colspan=1>CGZ</td></tr><tr><td rowspan=1 colspan=1>Lithium Test System</td><td rowspan=1 colspan=1>862.3560</td><td rowspan=1 colspan=1>Class II</td><td rowspan=1 colspan=1>JIH</td></tr></table>

Panel: Chemistry, 75 (6) Predicate Device:

Statement of Technology Characteristics of the Device Compared to Predicate Device:   

<table><tr><td rowspan=1 colspan=1>Description</td><td rowspan=1 colspan=1>510(k)</td><td rowspan=1 colspan=1>Analytes</td></tr><tr><td rowspan=1 colspan=1>GEMLTYE Electrolyte Analyzer Na*/K*/Cl$Ca^{2}/Li</td><td rowspan=1 colspan=1>K082462</td><td rowspan=1 colspan=1>Sodium, Potassium, Chloride,Calcium, Lithium</td></tr></table>

<table><tr><td rowspan=1 colspan=1>Operating Principle</td><td rowspan=1 colspan=1>Predicate Device</td><td rowspan=1 colspan=1>PROLYTE</td></tr><tr><td rowspan=1 colspan=1>Potentiometric Nat, K*, Cl, LiElectrodes</td><td rowspan=1 colspan=1>K070104</td><td rowspan=1 colspan=1>SAME</td></tr></table>

# (7) Device Description:

The PROLYTE Electrolyte Analyzer $N a ^ { + } / K ^ { + } / C l ^ { - } / L i ^ { + }$ is intended to be a direct replacement for the PROLYTE Elecrolyte Analyzer Na/K/Cl (k102959). The PROLYTE Na, K\*, Cl/LiElectrolyte Analyzer has all the features of the Diamond Prolyte ElectrolyteAnalyzer Na 10295), with the added feature that the CI ISE sensor may be replaced by a Li\* ISE sensor by the end-user.

The PROLYTE Electrolyte Analyzer Na/K/Cl/Liis designed for clinical laboratory use by labortory proessionals toassess the leves o Sodium, Potassium,Chloride and Lithium found i whole blood, plasma, a serum of patientsSodiu, Potassium, and Chloride are also assessed in urineof patients.The analysi is performed in-vitro, and neither the analyzer nor any of its components come in contact with the patient.

This bench top analyzer is used by trained laboratory technicians in clinical laboratories to aid in the diois naen  ptt wi elerolybalan  wel heontrng el t akLihTetsutiely oegulatisconc aiy ualy programs.

It uses the Diamond Diagnostics Fluid Pack (k031159) which contains in a sealed package the two calrants required or caliration along with a fush solution and a waste container. The analyzrcan e programmed to self-calibrate at set intervals or on request. The analyzer establishes a slope for the elerode by means of the two calibrants.A value or a sample s determined by direct comparison tohe calibrants. Mission Controls (k033063) are the recommended quality control material to be used daily.

# (8) Intended Use:

aIntended use(s):

The PROLYTE Electrolyte Analyzer Na\*/K†/Cl/Li is designed for clinical laboratory use by laboratory proessionals toassess the levelsf Sodium Potassium, Chloride and Lithim found in whole blood srum, plasa, andurine of patients.The analysis is perormed in-vitro, and neither the analyzer or any  it components come in contact with the patient.

This analyzer is used by trained laboratory technicians in clinical laboratories toaid in the diagnosis and en  pt olync ee vo pat lihi.These locations routinely conform toCLIA regulations, and conduct daily quality control programs.

b. Indication(s) for use:

The PROLYTE is an automated, microprocessor-controlled analyzer which utlizesion-selective electrodes for the measurement of sodium, potassium, chloride and lithium in whole blood, plasma, serum, and urine samples.

The PROLYTE Sodium Assay is intended to measure sodium in whole blood, plasma, serum, and urine on the PROLYTE Electrolyte Analyzer Na\*/K†/Cl/Li. Measurements obtained by this device are used to monitor electrolyte balance in the diagnosis and treatment of aldosteronism (excessive secretion of the hoe ldosteroneibetsipiusroniexcretionrgemountsluriccopan extreme thirst), adrenal hypertension, Addison's disease (caused by destruction of the adrenal glands), derationpopriantdiureoroecretineasnvolvinelecrolymba

The PROLYTE Potassium Assay is intended to measure potassium in whole blood, plasma, serum, and urine on the PROLTE Electrolyte Analyzer Na/K/CI/Li. Measurements obtained by this device are used monitorelectrolye balance nhediagnoss ndtreatmentdiseases conditonscharacterized by low high blood potassium levels.

The PROLYTE Chloride Assay is intended tomeasure the levelof chloride in whole blood, plasma, srum, and urine on the PROLYTE Electrolyte Analyzer Na/K\*/Cl/Li. Chloride measurements are used in the diagnosis andtreatment electrolyteandmetabolicdisorders such as ystfibrosis and diabeticacidsis.

The ROLYTE Lithim st sstemis nted measueithi rom heru lithi arbonati whol bloo, plasma, or serum on the PROLYTE Electrolyte Analyzer Na/K/CI/Li. Measurements of lithium are used to assure that the proper drug dosage is administered in the treatment of patients with mental disturbances, such as manic-depressive illness (bipolar disorder).

It is For In Vitro Diagnostic Use.

# (9) Technological Characteristics of the Device:

# Measurement Principles:

The principles of measurement used in the PROLYTE Electrolyte Analyzer Na/K/CI/L are identical to those principles existing in the predicate electrolyte analyzers GEMLYTE (k082462) and PROLYTE (k102959).

The PROLTE Electrolyte Analyzer Na/K/Cl/Lmeasures sodium, potassium, chloride and ithiu in whole blood, serum, plasma, and urine (except lithium), using ion selective electrode technology. The sodium electrode contains a glass tube, specially formulated to be sensitive to sodium ions. The potassium and lithium electrodes incorporate a neutral carrier ionophore membrane. The chloride

contains an ionophore covalently bound to a substrate which is sensitive to negatively charged ions. The pnilea electroesmesurelativ sableeernetablihe ya svesv chloride electrode in concentrated salt solution. The measured potential varies with the concentration of the ion sensed by the electrode.

# Comparison to Predicate Device:

The PROLYTE ${ \mathsf { N a } } ^ { * }$ , $\mathsf { K } ^ { + }$ , Cl, Lit\* Electrolyte Analyzer is an analyzer that has all the features of the Diamond Prolyte $\ N \mathsf { a } ^ { + }$ , $\mathsf { K } ^ { + }$ , Cl Electrolyte Analyzer (k102959), but the Cl ISE sensor may be replaced by a Li ISE sensor by the end-user. This is similar to the second predicate device, GEMLYTE $\boldsymbol { \mathsf { N a } } ^ { * }$ , $\mathsf { K } ^ { + }$ CI, $\cos ^ { 2 + }$ , Li\* Electrolyte Analyzer (k082462) where the Cl ISE sensor may be replaced by a Li\* or $\mathsf { C a } ^ { 2 + }$ ISE sensor by the end-user.

The default configuration of the PROLYTE Na\*, $K ^ { + }$ , Cl, Li\* Electrolyte Analyzer is $N a ^ { + } \cdot K ^ { + } \cdot C l ^ { - }$ . The user can select Li under the Operator Functions menu in the same manner as the selection is made in the predicate, GEMLYTE. Moreover, the Fluid Pack (k031159) used for calibration, flushing and waste storage is the same as the predicate PROLYTE device and the candidate device. To simplify operation of the PROLYTE, the menu structure was modified to be similar to SMARLTYE where there is a single menu level. The predicate PROLYTE had a Main Menu that could step into a Second Menu for certain functions.

Comparison Table below shows primary similarities and differences between the candidate device and the predicate devices.

<table><tr><td rowspan=1 colspan=2>Comparison to Predicate Device</td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1>Item</td><td rowspan=1 colspan=1>CANDIDATE DEVICE</td><td rowspan=1 colspan=1>PREDICATE</td></tr><tr><td rowspan=1 colspan=1>Trade/proprietary name</td><td rowspan=1 colspan=1>PROLYTE ELECTROLYTE ANALYZER</td><td rowspan=1 colspan=1>GEMLYTE</td></tr><tr><td rowspan=1 colspan=1>Model number</td><td rowspan=1 colspan=1>Na K CI Li</td><td rowspan=1 colspan=1>Na K Cl Ca Li</td></tr><tr><td rowspan=1 colspan=1>Manufacturer</td><td rowspan=1 colspan=1>Diamond Diagnostics Corp</td><td rowspan=1 colspan=1>Diamond Diagnostics Corp</td></tr><tr><td rowspan=1 colspan=1>510(k)/PMA reference number</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>K082462</td></tr><tr><td rowspan=1 colspan=1>Intended use</td><td rowspan=1 colspan=1>Sodium, Potassium, Chloride, Lithiumdetermination</td><td rowspan=1 colspan=1>Also has Calcium</td></tr><tr><td rowspan=1 colspan=1>Sample Type</td><td rowspan=1 colspan=1>Blood, serum, plasma, urine</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Measurement Principle</td><td rowspan=1 colspan=1>Ion Selective Electrodes</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Analysis time, blood</td><td rowspan=1 colspan=1>59 sec</td><td rowspan=1 colspan=1>57 sec</td></tr><tr><td rowspan=1 colspan=1>Analysis time, Urine</td><td rowspan=1 colspan=1>69 sec</td><td rowspan=1 colspan=1>57</td></tr><tr><td rowspan=1 colspan=1>Measurement Range, Blood</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1>Na</td><td rowspan=1 colspan=1>45 - 205 mEq/L</td><td rowspan=1 colspan=1>40 - 200 mEq/L</td></tr><tr><td rowspan=1 colspan=1>K</td><td rowspan=1 colspan=1>1.5- 11 mEq/L         </td><td rowspan=1 colspan=1>1.7- 15 mEq/L</td></tr><tr><td rowspan=1 colspan=1>CI</td><td rowspan=1 colspan=1>45- 205 mEq/L</td><td rowspan=1 colspan=1>50 - 200 mEq/L</td></tr><tr><td rowspan=1 colspan=1>Li</td><td rowspan=1 colspan=1>0.15 - 5.0 mEq/L</td><td rowspan=1 colspan=1>0.2 - 5.5 mEq/L</td></tr><tr><td rowspan=1 colspan=1>Measurement Range, Urine</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1>Na</td><td rowspan=1 colspan=1>25 - 1020 mEq/L</td><td rowspan=1 colspan=1>3-300 mEq/L</td></tr><tr><td rowspan=1 colspan=1>K</td><td rowspan=1 colspan=1>10 - 505 mEq/L</td><td rowspan=1 colspan=1>5 - 120 mEq/L</td></tr><tr><td rowspan=1 colspan=1>CI</td><td rowspan=1 colspan=1>25 - 505 mEq/L</td><td rowspan=1 colspan=1>15 - 300 mEq/L</td></tr><tr><td rowspan=1 colspan=1>Sodium: Blood, Plasma, Serum Precision</td><td rowspan=1 colspan=1>cYMNlow</td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1>Expected, within run CV</td><td rowspan=1 colspan=1>=1%</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Expected, between run CV</td><td rowspan=1 colspan=1>=2%</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Potassium: Blood, Plasma, Serum Precision</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1>Expected, within run CV</td><td rowspan=1 colspan=1>=2%</td><td rowspan=1 colspan=1>≤ 1.5%</td></tr><tr><td rowspan=1 colspan=1>Expected, between run CV</td><td rowspan=1 colspan=1>= 2.5 %</td><td rowspan=1 colspan=1>≤3%</td></tr><tr><td rowspan=1 colspan=1>Chloride: Blood, Plasma, Serum Precision</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1>Expected, within run CV</td><td rowspan=1 colspan=1>=2%</td><td rowspan=1 colspan=1>≤1%</td></tr><tr><td rowspan=1 colspan=1>Expected, between run CV</td><td rowspan=1 colspan=1>=2.5 %</td><td rowspan=1 colspan=1>≤3%</td></tr><tr><td rowspan=1 colspan=1>Lithium: Blood, Plasma, Serum Precision</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1>Expected, within run sd</td><td rowspan=1 colspan=1>≤ 0.03</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Expected, between run sd</td><td rowspan=1 colspan=1>≤ 0.09</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Sodium: Urine Precision</td><td rowspan=1 colspan=1>E</td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1>Expected, within run CV</td><td rowspan=1 colspan=1>=2.5 %</td><td rowspan=1 colspan=1>≤5%</td></tr><tr><td rowspan=1 colspan=1>Expected, between run CV</td><td rowspan=1 colspan=1>=5%</td><td rowspan=1 colspan=1>≤5%</td></tr><tr><td rowspan=1 colspan=1>Potassium: Urine Precision</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1>Expected, within run CV</td><td rowspan=1 colspan=1>=2.5%</td><td rowspan=1 colspan=1>≤5%</td></tr><tr><td rowspan=1 colspan=1>Expected, between run CV</td><td rowspan=1 colspan=1>=5%</td><td rowspan=1 colspan=1>≤5%</td></tr><tr><td rowspan=1 colspan=1>Chloride: Urine Precision</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1>Expected, within run CV</td><td rowspan=1 colspan=1>=2.5 %</td><td rowspan=1 colspan=1>≤5%</td></tr><tr><td rowspan=1 colspan=1>Expected, between run CV</td><td rowspan=1 colspan=1>=5%</td><td rowspan=1 colspan=1>≤5%</td></tr><tr><td rowspan=1 colspan=1>Calibration</td><td rowspan=1 colspan=1>Automatic and on Demand</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Reagent Pack</td><td rowspan=1 colspan=1>800 ml Fluid Pack</td><td rowspan=1 colspan=1>350 ml Fluid Pack</td></tr><tr><td rowspan=1 colspan=1>QC storage</td><td rowspan=1 colspan=1>LEVELS 1, 2, 3 (500 each)</td><td rowspan=1 colspan=1>QC Levels 1, 2, 3 results, total 35</td></tr><tr><td rowspan=1 colspan=1>Sample Results Storage</td><td rowspan=1 colspan=1>1000</td><td rowspan=1 colspan=1>Last Sample</td></tr><tr><td rowspan=1 colspan=1>Sample Data Recall</td><td rowspan=1 colspan=1>Recall by Date and Sample ID added</td><td rowspan=1 colspan=1>Last Sample</td></tr><tr><td rowspan=3 colspan=1>Output</td><td rowspan=1 colspan=1>32 character, 2 line alphanumericdisplay</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>40 column thermal printer</td><td rowspan=1 colspan=1>16 Column thermal printer</td></tr><tr><td rowspan=1 colspan=1>RS-232 Serial port</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Power Requirements</td><td rowspan=1 colspan=1>100-240V 50/60Hz 1.6 A</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Microcontroller processor</td><td rowspan=1 colspan=1>Microchip dsPIC33FJ256</td><td rowspan=1 colspan=1>Freescale 68HC16</td></tr><tr><td rowspan=1 colspan=1>Program Flow</td><td rowspan=1 colspan=1>Single level menu structure</td><td rowspan=1 colspan=1>Single level menu structure</td></tr></table>

# (10) Summary of non-clinical tests:

Precision - Sodium, Potassium and Chloride in whole blood, plasma, serum and urine were previously cleared (K105929).

Lihi precision was calculated with results from ive whole blood, plasma and serum samples.The smple concentrations were at the reportable lmits as well as low and high end of reference ranges and near he md pnt rangFor within un precisin, 30replicates  each smple without caliratin between measurent were collected. The replicates were run consecutively in one day

Total precision was determined by measuring the plasma and serum samples twice each morning and twice ea afternoon for ten days resulting in 0 replicates Whole blood total precision was conducted in a igle dyetbilitblwhol bloli atl w collecLha pen wite mefibelweenn mEq/L..

<table><tr><td></td><td>Within Run</td><td>Run to Run</td><td></td></tr><tr><td>Lit</td><td>S.D. ≤ 0.03</td><td>≤ 0.09</td><td>(0.3 - 2.0 mEq/L)</td></tr></table>

The tables below show the precision results.

Whole Blood, mEq/L   

<table><tr><td rowspan=1 colspan=1>WITHIN RUN</td><td rowspan=1 colspan=1>V Low</td><td rowspan=1 colspan=1>Low</td><td rowspan=1 colspan=1>Mid</td><td rowspan=1 colspan=1>High9</td><td rowspan=1 colspan=1>:V High</td></tr><tr><td rowspan=1 colspan=1>Mean</td><td rowspan=1 colspan=1>0.216</td><td rowspan=1 colspan=1>0.607</td><td rowspan=1 colspan=1>1.035</td><td rowspan=1 colspan=1>1.727</td><td rowspan=1 colspan=1>4.153</td></tr><tr><td rowspan=1 colspan=1>SD</td><td rowspan=1 colspan=1>0.010</td><td rowspan=1 colspan=1>0.008</td><td rowspan=1 colspan=1>0.009</td><td rowspan=1 colspan=1>0.010</td><td rowspan=1 colspan=1>0.030</td></tr><tr><td rowspan=1 colspan=1>%CV</td><td rowspan=1 colspan=1>4.76  1</td><td rowspan=1 colspan=1>1.24</td><td rowspan=1 colspan=1>0.82</td><td rowspan=1 colspan=1>0.57</td><td rowspan=1 colspan=1>: 0.72</td></tr><tr><td rowspan=1 colspan=1>N</td><td rowspan=1 colspan=1>30</td><td rowspan=1 colspan=1>30</td><td rowspan=1 colspan=1>30</td><td rowspan=1 colspan=1>30</td><td rowspan=1 colspan=1>30</td></tr><tr><td rowspan=1 colspan=1>Spec, BLD</td><td rowspan=1 colspan=1>0.03</td><td rowspan=1 colspan=1>0.03</td><td rowspan=1 colspan=1>0.03</td><td rowspan=1 colspan=1>0.03</td><td rowspan=1 colspan=1>0.03</td></tr><tr><td rowspan=1 colspan=1>PASS/FAIL</td><td rowspan=1 colspan=1>P</td><td rowspan=1 colspan=1>P</td><td rowspan=1 colspan=1>P</td><td rowspan=1 colspan=1>P</td><td rowspan=1 colspan=1>P</td></tr></table>

<table><tr><td rowspan=1 colspan=1>RUN TO RUN</td><td rowspan=1 colspan=1>V Low </td><td rowspan=1 colspan=1>Low</td><td rowspan=1 colspan=1>Mid</td><td rowspan=1 colspan=1>High</td><td rowspan=1 colspan=1>V High</td></tr><tr><td rowspan=1 colspan=1>Mean</td><td rowspan=1 colspan=1>0.227</td><td rowspan=1 colspan=1>0.607</td><td rowspan=1 colspan=1>1.031</td><td rowspan=1 colspan=1>1.740</td><td rowspan=1 colspan=1>4.171</td></tr><tr><td rowspan=1 colspan=1>SD</td><td rowspan=1 colspan=1>0.014</td><td rowspan=1 colspan=1>0.009</td><td rowspan=1 colspan=1>0.010</td><td rowspan=1 colspan=1>0.009</td><td rowspan=1 colspan=1>0.036</td></tr><tr><td rowspan=1 colspan=1>:.%CV</td><td rowspan=1 colspan=1>6.31$</td><td rowspan=1 colspan=1>1.56</td><td rowspan=1 colspan=1>0.95</td><td rowspan=1 colspan=1>0.52</td><td rowspan=1 colspan=1>0.85</td></tr><tr><td rowspan=1 colspan=1>N</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>40</td></tr><tr><td rowspan=1 colspan=1>Spec, BLD</td><td rowspan=1 colspan=1>0.09</td><td rowspan=1 colspan=1>0.09</td><td rowspan=1 colspan=1>0.09</td><td rowspan=1 colspan=1>0.09</td><td rowspan=1 colspan=1>0.09</td></tr><tr><td rowspan=1 colspan=1>PASS/FAIL</td><td rowspan=1 colspan=1>P</td><td rowspan=1 colspan=1>P</td><td rowspan=1 colspan=1>P</td><td rowspan=1 colspan=1>P</td><td rowspan=1 colspan=1>P</td></tr></table>

Plasma, mEq/L   

<table><tr><td rowspan=1 colspan=1>Within Run</td><td rowspan=1 colspan=1>V Low</td><td rowspan=1 colspan=1>Low</td><td rowspan=1 colspan=1>ilMid</td><td rowspan=1 colspan=1>High</td><td rowspan=1 colspan=1>V High</td></tr><tr><td rowspan=1 colspan=1>Mean</td><td rowspan=1 colspan=1>0.32130</td><td rowspan=1 colspan=1>0.62003</td><td rowspan=1 colspan=1>1.09253</td><td rowspan=1 colspan=1>2.29560</td><td rowspan=1 colspan=1>4.41513</td></tr><tr><td rowspan=1 colspan=1>SD</td><td rowspan=1 colspan=1>0.00531</td><td rowspan=1 colspan=1>0.00482</td><td rowspan=1 colspan=1>0.00308</td><td rowspan=1 colspan=1>0.01336</td><td rowspan=1 colspan=1>0.06310</td></tr><tr><td rowspan=1 colspan=1>%CV</td><td rowspan=1 colspan=1>1.65</td><td rowspan=1 colspan=1>0.78</td><td rowspan=1 colspan=1>0.28</td><td rowspan=1 colspan=1>0.58</td><td rowspan=1 colspan=1>1.43</td></tr><tr><td rowspan=1 colspan=1>N</td><td rowspan=1 colspan=1>30</td><td rowspan=1 colspan=1>30</td><td rowspan=1 colspan=1>30</td><td rowspan=1 colspan=1>30</td><td rowspan=1 colspan=1>30</td></tr><tr><td rowspan=1 colspan=1>Spec, BLD</td><td rowspan=1 colspan=1>0.03</td><td rowspan=1 colspan=1>0.03</td><td rowspan=1 colspan=1>0.03</td><td rowspan=1 colspan=1>0.03</td><td rowspan=1 colspan=1>0.03</td></tr><tr><td rowspan=1 colspan=1>PASS/FAIL</td><td rowspan=1 colspan=1>P</td><td rowspan=1 colspan=1>P</td><td rowspan=1 colspan=1>P</td><td rowspan=1 colspan=1>P</td><td rowspan=1 colspan=1>F</td></tr></table>

<table><tr><td rowspan=1 colspan=1>Run to Run</td><td rowspan=1 colspan=1>VLow</td><td rowspan=1 colspan=1>Low</td><td rowspan=1 colspan=1>H00Mid</td><td rowspan=1 colspan=1>High</td><td rowspan=1 colspan=1>V High</td></tr><tr><td rowspan=1 colspan=1>Mean</td><td rowspan=1 colspan=1>0.32668</td><td rowspan=1 colspan=1>0.62789</td><td rowspan=1 colspan=1>1.09495</td><td rowspan=1 colspan=1>2.28523</td><td rowspan=1 colspan=1>4.37893</td></tr><tr><td rowspan=1 colspan=1>SD</td><td rowspan=1 colspan=1>0.01462</td><td rowspan=1 colspan=1>0.00682</td><td rowspan=1 colspan=1>0.00666</td><td rowspan=1 colspan=1>0.02444</td><td rowspan=1 colspan=1>0.06651</td></tr><tr><td rowspan=1 colspan=1>%CV</td><td rowspan=1 colspan=1>4.47.</td><td rowspan=1 colspan=1>1.09</td><td rowspan=1 colspan=1>.0.61</td><td rowspan=1 colspan=1>1.07</td><td rowspan=1 colspan=1>&#x27;1.52</td></tr><tr><td rowspan=1 colspan=1>N</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>44</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>41</td></tr><tr><td rowspan=1 colspan=1>Spec, BLD</td><td rowspan=1 colspan=1>0.09</td><td rowspan=1 colspan=1>0.09</td><td rowspan=1 colspan=1>0.09</td><td rowspan=1 colspan=1>0.09</td><td rowspan=1 colspan=1>0.09</td></tr><tr><td rowspan=1 colspan=1>PASS/FAIL</td><td rowspan=1 colspan=1>P</td><td rowspan=1 colspan=1>P</td><td rowspan=1 colspan=1>P</td><td rowspan=1 colspan=1>P</td><td rowspan=1 colspan=1>P</td></tr></table>

Serum, mEq/L   

<table><tr><td rowspan=1 colspan=1>Within Run</td><td rowspan=1 colspan=1>VLow</td><td rowspan=1 colspan=1>.:sLow</td><td rowspan=1 colspan=1>Mld</td><td rowspan=1 colspan=1>High</td><td rowspan=1 colspan=1>V High</td></tr><tr><td rowspan=1 colspan=1>Mean</td><td rowspan=1 colspan=1>0.25563</td><td rowspan=1 colspan=1>0.59367</td><td rowspan=1 colspan=1>1.05813</td><td rowspan=1 colspan=1>1.99907</td><td rowspan=1 colspan=1>4.30820</td></tr><tr><td rowspan=1 colspan=1>SD</td><td rowspan=1 colspan=1>0.00844</td><td rowspan=1 colspan=1>0.00646</td><td rowspan=1 colspan=1>0.00445</td><td rowspan=1 colspan=1>0.01166</td><td rowspan=1 colspan=1>0.04239</td></tr><tr><td rowspan=1 colspan=1>%CV</td><td rowspan=1 colspan=1>3.30</td><td rowspan=1 colspan=1>1.09</td><td rowspan=1 colspan=1>0.42</td><td rowspan=1 colspan=1>0.58</td><td rowspan=1 colspan=1>0.98</td></tr><tr><td rowspan=1 colspan=1>N</td><td rowspan=1 colspan=1>30</td><td rowspan=1 colspan=1>30</td><td rowspan=1 colspan=1>30</td><td rowspan=1 colspan=1>30</td><td rowspan=1 colspan=1>30</td></tr><tr><td rowspan=1 colspan=1>Spec, BLD</td><td rowspan=1 colspan=1>0.03</td><td rowspan=1 colspan=1>0.03</td><td rowspan=1 colspan=1>0.03</td><td rowspan=1 colspan=1>0.03</td><td rowspan=1 colspan=1>0.03</td></tr><tr><td rowspan=1 colspan=1>PASS/FAIL</td><td rowspan=1 colspan=1>P</td><td rowspan=1 colspan=1>P</td><td rowspan=1 colspan=1>P</td><td rowspan=1 colspan=1>P</td><td rowspan=1 colspan=1>F</td></tr></table>

<table><tr><td rowspan=1 colspan=1>Run to Run</td><td rowspan=1 colspan=1>V Low</td><td rowspan=1 colspan=1>Low</td><td rowspan=1 colspan=1>Mid</td><td rowspan=1 colspan=1>High</td><td rowspan=1 colspan=1>V High</td></tr><tr><td rowspan=1 colspan=1>Mean</td><td rowspan=1 colspan=1>0.2928</td><td rowspan=1 colspan=1>0.5956</td><td rowspan=1 colspan=1>1.0610</td><td rowspan=1 colspan=1>2.0073</td><td rowspan=1 colspan=1>4.3562</td></tr><tr><td rowspan=1 colspan=1>SD</td><td rowspan=1 colspan=1>0.0280</td><td rowspan=1 colspan=1>0.0164</td><td rowspan=1 colspan=1>0.0074</td><td rowspan=1 colspan=1>0.0425</td><td rowspan=1 colspan=1>0.0824</td></tr><tr><td rowspan=1 colspan=1>%CV</td><td rowspan=1 colspan=1>9.56</td><td rowspan=1 colspan=1>: 2.76</td><td rowspan=1 colspan=1>0.70</td><td rowspan=1 colspan=1>2.12.</td><td rowspan=1 colspan=1>1.89</td></tr><tr><td rowspan=1 colspan=1>N</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>40</td></tr><tr><td rowspan=1 colspan=1>Spec, BLD</td><td rowspan=1 colspan=1>0.09</td><td rowspan=1 colspan=1>0.09</td><td rowspan=1 colspan=1>0.09</td><td rowspan=1 colspan=1>0.09</td><td rowspan=1 colspan=1>0.09</td></tr><tr><td rowspan=1 colspan=1>PASS/FAIL</td><td rowspan=1 colspan=1>P</td><td rowspan=1 colspan=1>P</td><td rowspan=1 colspan=1>P</td><td rowspan=1 colspan=1>P</td><td rowspan=1 colspan=1>P</td></tr></table>

Linearity - Sodium, Potassium and Chloride in whole blood, plasma, serum and urine were previously cleared (K105929).

Linearity was evaluated by preparing stock solutin wih a high concentration of Liin whole blood plasa and serum. The stock was diluted serially $(20 \% )$ to concentrations across the measuring ranges of each analyte and matrix. Linear regression was performed using expected values based on the stock sample dilution. The results are shown below.

Lithium Linearity, Measured compared to Expected Values, mEq/L   

<table><tr><td>Parameter</td><td>Slope</td><td>Intercept</td><td>R{</td><td>Range</td><td>n</td></tr><tr><td>Whole blood</td><td>0.9854</td><td>-0.0285</td><td>0.9979</td><td>0.15 - 5.5</td><td>100</td></tr><tr><td>Plasma</td><td>0.9985</td><td>-0.0315</td><td>0.9997</td><td>0.1 - 5.9</td><td>38</td></tr><tr><td>Serum</td><td>1.0068</td><td>0.019</td><td>0.9998</td><td>0.1 - 5.7</td><td>44</td></tr></table>

The linearity studies support the following reportable range.

<table><tr><td>Measuri Serum</td><td></td></tr></table>

(11) Summary of clinical tests submitted with the pre-market notification for the device.

Sodium, Potassium and Chloride in whole blood, plasma, serum and urine were previously cleared (K105929).

Method comparison to predicate device was performed with whole blood, plasma, serum patient samples. Some samples were spiked or diluted to fully span the claimed measuring range. The results are summarized below.

PROLYTE Li versus Predicate, GEMLYTE (k082462) in Various Matrices, Lithium mEq/L   

<table><tr><td>Parameter</td><td>Slope</td><td>Intercept</td><td>$R^{2$</td><td>Range</td><td>n</td></tr><tr><td>Whole Blood</td><td>1.0096</td><td>0.0719</td><td>0.9947</td><td>0.15 - 5.0</td><td>94</td></tr><tr><td>Plasma</td><td>0.9806</td><td>0.1292</td><td>0.9971</td><td>0.16 - 5.0</td><td>100</td></tr><tr><td>Serum</td><td>0.9977</td><td>0.0133</td><td>0.9881</td><td>0.17- 4.7</td><td>91</td></tr></table>

The method comparison studies support correlation in the reportable range.

<table><tr><td>Measuri Serum</td><td></td></tr></table>

(12) Conclusions drawn from the clinical and non-clinical testing.

Analysis of the comparative measurement presented in the $5 1 0 ( k )$ for this device, together with the linearity and precision data collected during these clinical and non-clinical trails demonstrates that the Diamond Diagnostics PROLYTE Electrolyte Analyzer lithium test system is safe, effective and substantially equivalent to its predicate device, the GEMLYTE (K082462).

Diamond Diagnostics, Inc.   
c/o Kathy Cruz, Quality Assurance Manager 333 Fiske St.   
Holliston, MA 01746

Re: k121140 Trade Name: PROLYTE Electrolyte Analyzer Na+/K+/Cl-/Li+ Regulation Number: 21 CFR $\ S 8 6 2 . 3 5 6 0$ Regulation Name: Lithium test system Regulatory Class: Class II Product Codes: JIH, JGS, CEM, CGZ Dated: July 24, 2012 Received: July 31, 2012

Dear Ms. Cruz:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in Title 21, Code of Federal Regulations (CFR), Parts 800 to 895. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Parts 801 and 809); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); and good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820).

Page 2

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of In Vitro Diagnostic Device Evaluation and Safety at (301) 796-5450. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding postmarket surveillance, please contact CDRH's Office of Surveillance and Biometric's (OSB's) Division of Postmarket Surveillance at (301) 796-5760. For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/Medical   
Devices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance...

You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-5680 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm

Sincerely yours,

![](images/511bf7c85be80a22abf3ba49ffd45ec12761a62fe30e7a33d1200f5e066c782d.jpg)

Couplney H. Lias, Ph.D.   
Director   
Division of Chemistry and Toxicology Devices Office of In Vitro Diagnostic Device   
Evaluation and Safety   
Center for Devices and Radiological Health

# Indications for Use

510 (k) Number (if nown)1211

Device Name: PROLYTE Electrolyte Analyzer Na\*/K+/CI/Li\*

Indication For Use:

Th PROLTE ElectrolyteAnalyzer NaK/C/Li is an automated, microprocessor-controlled analyzer which ul-eleeeeeuentpoasslorhwo plasma, and serum. Sodium, potassium, and chloride can be measured in urine samples.

The PROLYTE Sodium Assay is intended tomeasure sodium in whole blood, plasma, serum, and urine n he PROLYTE Electrolyte Analyzer Na\*/K†/Cl/Li. Measurements obtained by this device are used to monitor electrolyte balance in the diagnosis and treatment of aldosteronism (excessive secretion of the hormone alosteronedibetesinsipidus roniexcretionargemounts iluteuraccopani yee thirst), adrenal hypertension, Addison's disease (caused by destruction of the adrenal glands), dehydration, inappropriate antidiuretic hormone secretion, or other diseases involving electrolyte imbalance.

The PROLYTE Potassium Assay is intended to measure potassium in whole blood, plasma, serum, and urine ROLE ElectrolyteAnalyzer aKC/LMeasurmets btained b thi device eused t elecrolytebalance in thediagnosis and treatment isease conditions characterized b low rhigh blood potassium levels.

ThROLTChlorAssay stend easehe evelori  whole blood pasmer uon the ROLE Electrolyte Analyzer Na/KCl/LiChloride measurements are sed in the diagosis and treatment of electrolyte and metabolic disorders such as cystic fibrosis and diabetic acidosis.

T ROLY sthaho poalz / p illness (bipolar disorder).

Prescription Use X And/Or (21 CFR Part 801 Subpart D)

Concurrence of CDRH, Office of In Vitro Diagnostic Devices (OIVD)

![](images/cc5a85ebb8319179454b0b6ed946950f525505a1afdaee2da8f88ab11354813c.jpg)

Division Sign-Off Office of In Vitro Diagnostic Device Evaluation and Safety